Free Trial

Alvotech (ALVOW) Competitors

Alvotech logo
$0.45 0.00 (0.00%)
As of 10/7/2026

ALVOW vs. APLMW, ARAV, BIAFW, BIVIW, and CDIOW

Should you buy Alvotech stock or one of its competitors? Alvotech's main competitors and comparable companies include Apollomics (APLMW), Aravive (ARAV), bioAffinity Technologies (BIAFW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "biotechnology" industry.

How does Alvotech compare to Apollomics?

Alvotech (NASDAQ:ALVOW) and Apollomics (NASDAQ:APLMW) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, risk, dividends, profitability, analyst recommendations, earnings and valuation.

In the previous week, Alvotech had 3 more articles in the media than Apollomics. MarketBeat recorded 3 mentions for Alvotech and 0 mentions for Apollomics. Alvotech's average media sentiment score of 0.70 beat Apollomics' score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
Apollomics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Apollomics N/A N/A N/A

Summary

Alvotech beats Apollomics on 3 of the 3 factors compared between the two stocks.

How does Alvotech compare to Aravive?

Alvotech (NASDAQ:ALVOW) and Aravive (NASDAQ:ARAV) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, valuation, institutional ownership, earnings, analyst recommendations, risk, media sentiment and profitability.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
AraviveN/AN/AN/A-$0.90N/A

35.8% of Aravive shares are owned by institutional investors. 60.4% of Aravive shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Aravive N/A N/A N/A

In the previous week, Alvotech had 3 more articles in the media than Aravive. MarketBeat recorded 3 mentions for Alvotech and 0 mentions for Aravive. Alvotech's average media sentiment score of 0.70 beat Aravive's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
Aravive Neutral

Summary

Alvotech beats Aravive on 3 of the 5 factors compared between the two stocks.

How does Alvotech compare to bioAffinity Technologies?

bioAffinity Technologies (NASDAQ:BIAFW) and Alvotech (NASDAQ:ALVOW) are both healthcare companies, but which is the superior business? We will contrast the two businesses based on the strength of their profitability, risk, earnings, dividends, valuation, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Alvotech had 2 more articles in the media than bioAffinity Technologies. MarketBeat recorded 3 mentions for Alvotech and 1 mentions for bioAffinity Technologies. Alvotech's average media sentiment score of 0.70 beat bioAffinity Technologies' score of -0.78 indicating that Alvotech is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
bioAffinity Technologies
0 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Negative
Alvotech
1 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Company Net Margins Return on Equity Return on Assets
bioAffinity TechnologiesN/A N/A N/A
Alvotech N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
bioAffinity Technologies$5.85MN/AN/AN/AN/A
Alvotech$491.95MN/AN/AN/AN/A

Summary

Alvotech beats bioAffinity Technologies on 3 of the 3 factors compared between the two stocks.

How does Alvotech compare to BioVie?

Alvotech (NASDAQ:ALVOW) and BioVie (NASDAQ:BIVIW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their dividends, valuation, media sentiment, earnings, analyst recommendations, institutional ownership, profitability and risk.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

In the previous week, Alvotech had 3 more articles in the media than BioVie. MarketBeat recorded 3 mentions for Alvotech and 0 mentions for BioVie. Alvotech's average media sentiment score of 0.70 beat BioVie's score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
BioVie Neutral

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
BioVie N/A N/A N/A

Summary

Alvotech beats BioVie on 3 of the 3 factors compared between the two stocks.

How does Alvotech compare to Cardio Diagnostics?

Alvotech (NASDAQ:ALVOW) and Cardio Diagnostics (NASDAQ:CDIOW) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, dividends, analyst recommendations, valuation, earnings and media sentiment.

In the previous week, Alvotech had 3 more articles in the media than Cardio Diagnostics. MarketBeat recorded 3 mentions for Alvotech and 0 mentions for Cardio Diagnostics. Alvotech's average media sentiment score of 0.70 beat Cardio Diagnostics' score of 0.00 indicating that Alvotech is being referred to more favorably in the media.

Company Overall Sentiment
Alvotech Positive
Cardio Diagnostics Neutral

Company Net Margins Return on Equity Return on Assets
AlvotechN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alvotech$491.95MN/AN/AN/AN/A
Cardio Diagnostics$14.45KN/AN/AN/AN/A

Summary

Alvotech beats Cardio Diagnostics on 3 of the 3 factors compared between the two stocks.

Get Alvotech News Delivered to You Automatically

Sign up to receive the latest news and ratings for ALVOW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ALVOW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ALVOW vs. The Competition

MetricAlvotechBiotechnology IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$3.82B$7.12B$13.20B
Dividend YieldN/A3.66%2.53%16.47%
P/E RatioN/A13.59275.6125.91
Price / SalesN/A1,174.20566.1983.48
Price / CashN/A118.3777.4152.81
Price / BookN/A16.0710.786.25
Net IncomeN/A-$22.69M$3.50B$382.13M
7 Day Performance69.85%-3.60%-2.15%-1.55%
1 Month Performance52.15%-12.81%-7.66%-5.78%
1 Year Performance-69.41%9.17%3.16%-1.67%

Alvotech Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ALVOW
Alvotech
N/A$0.45
flat
N/A-70.6%$0.00$491.95MN/A4
APLMW
Apollomics
N/A$0.01
flat
N/A-47.1%$0.00$8.50MN/A15
ARAV
Aravive
N/A$0.04
flat
N/AN/A$0.00N/AN/A20
BIAFW
bioAffinity Technologies
N/A$0.28
-12.5%
N/A+73.4%$0.00$5.85MN/A10
BIVIW
BioVie
N/A$0.29
-5.0%
N/AN/A$0.00N/AN/AN/A

Related Companies and Tools


This page (NASDAQ:ALVOW) was last updated on 10/8/2026 by MarketBeat.com Staff.
From Our Partners